RC2 Alcohol-induced human striatal dopamine release related to alcoholism vulnera
RC2 Alcohol-induced human striatal dopamine release related to alcoholism vulnera
批准号:
8128248
负责人:
Anissa Abi-Dargham
金额:
$25.46万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-07-15 至 2016-05-31
关键词:
AddressAgeAge-YearsAgreementAlcohol consumptionAlcohol dependenceAlcoholismAlcoholsAmphetaminesAnimalsBehaviorBehavioralBiological MarkersBiologyBody WaterBrainComplementCorpus striatum structureCuesDataData SetDependenceDevelopmentDopamineEquilibriumEthnic OriginExperimental DesignsFamilyFunctional disorderGenderGlutamatesHabitsHumanJuiceLeadLearningMeasuresMediatingMetabolismMidbrain structureModelingMolecularOral AdministrationPartition CoefficientPatientsPharmaceutical PreparationsPopulationPositron-Emission TomographyPredisposing FactorPrevention strategyProcessPunishmentRacloprideRecording of previous eventsRelative (related person)ResearchResolutionRewardsRiskRisk FactorsRodentSamplingScanningSmell PerceptionSpatial DistributionStagingStimulusTaste PerceptionTestingTherapeuticVentral Striatumaddictionalcohol behavioralcohol exposurealcohol responsebasecostdesigndopamine systemdopaminergic neurondrinkinghealthy volunteerhigh riskneuroimagingpreclinical studyproblem drinkerradiotracerreceptorreceptor densityresponsereward circuitrysocioeconomicstooltranslational neurosciencetransmission processtreatment strategy
中文摘要
CTNA 3将测试中心假设,即酒精中毒的遗传风险反映了皮质纹状体-中脑回路的功能障碍,由谷氨酸和多巴胺的相互作用介导,使人们对药物样奖励的反应偏向于延迟奖励/惩罚。这种对药物样奖励的反应偏差导致了对酒精相关协会的学习增强,并促进了习惯性饮酒的发展。P2将通过评估风险受试者和酒精中毒患者纹状体中酒精诱导的多巴胺(DA)释放来验证这一假设,以证明风险与纹状体中酒精诱导的DA释放增加相关,而从风险到习惯的转变与反应降低相关。因此,DA介导成瘾倾向,并通过成瘾过程改变。SA #1。将在22名家族史阳性(FHP)健康志愿者和22名FH阴性(FHN)健康志愿者中使用D2/3受体放射性示踪剂[[11]C]雷氯必利进行PET扫描。各组将根据年龄、性别、种族、社会经济背景和饮酒习惯进行匹配。所有受试者的年龄均为21 - 25岁。[[11]C]雷氯必利扫描将在以0.75 g酒精/kg身体水的剂量口服酒精或以平衡顺序在不同的两天内饮用假饮料后获得。将测量腹侧纹状体[[11]C]雷氯必利特异性与非特异性平衡分配系数(BPND),并在两组之间进行比较。将比较两组间酒精诱导的[[11]C]雷氯必利BP{ND}(ABP{ND})降低。SA #2。在纹状体,
与匹配的健康对照组(n = 20)相比,酒精受试者(n = 20)中酒精诱导的DA突触内释放减少。将使用与SAI相同的实验设计。各组将根据年龄(25至45岁)、性别、种族、社会经济背景和饮酒习惯进行匹配。受试者为非寻求治疗的酗酒受试者。将比较两组之间酒精诱导的[[11]C]雷氯必利BP{ND}降低。
我们还将检验FHP受试者(n = 22)的基线[[11]C]雷氯必利BP{ND}是否低于FHN受试者(n = 22)(EA 3),并探索巴甫洛夫仪器性转移的倾向是否预测了来自SA 1的所有44例受试者中形成酒精相关习惯的倾向。
英文摘要
CTNA3 will test the central hypothesis that the heritable risk for alcoholism reflects dysfunction of corticostriatal-midbrain circuitry, mediated by the interplay of glutamate and dopamine, that biases people to respond to drug-like rewards relative to delayed reward/punishments. This bias to respond to drug-like rewards leads to enhanced learning of alcohol-related associations, and facilitation of the development of habitual alcohol consumption. P2 will test this hypothesis by assessing alcohol induced dopamine (DA) release in the striatum in at risk subjects and in patients with alcoholism to demonstrate that risk is associated with an increased alcohol-induced DA release in the striatum while the transition from risk to habit is associated with a decreased response. Thus DA mediates the propensity to become addicted, and is altered by the process of addiction. SA #1. PET scanning will be performed with the D2/3 receptor radiotracer [[11]C]raclopride in 22 family history positive (FHP) healthy volunteers versus 22 FH negative (FHN) healthy volunteers. Groups will be matched on age, gender, ethnicity, socioeconomic background, and drinking habits. All subjects will be 21 to 25 years of age. [[11]C]raclopride scans will be obtained following the administration of oral alcohol at 0.75 g alcohol per kg body water or a sham drink on two separate days in counterbalanced order. The ventrostriatal [[11]C]raclopride specific to nonspecific equilibrium partition coefficient (BPND) will be measured and compared between the two groups. Alcohol-induced reduction in [[11]C]raclopride BP{ND} (ABP{ND}) will be compared between the two groups. SA#2. In the striatum,
alcohol-induced DA intrasynaptic release is decreased in alcoholic subjects (n = 20) compared to matched healthy controls (n = 20). The same experimental design will be used as in SAI. Groups will be matched on age (25 to 45), gender, ethnicity, socioeconomic background, and drinking habits. Subjects will be nontreatment-seeking subjects with alcoholism. Alcohol-induced reduction in [[11]C]raclopride BP{ND} will be compared between the two groups.
We will also test if baseline [[11]C]raclopride BP{ND} in FHP subjects (n = 22) is lower compared to FHN subjects (n = 22) (EA3) and explore if the propensity for Pavlovian Instrumental Transfer predicts the propensity to develop alcohol-related habit in all 44 subjects from SA1.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Deep rTMS modulating insula synaptic density and smoking behavior in schizophrenia
-
批准号:10710181
-
项目类别:
-
资助金额:$35.86万
-
财政年份:2022
-
负责人:Anissa Abi-Dargham
-
依托单位:
Deep rTMS modulating insula synaptic density and smoking behavior in schizophrenia
-
批准号:10494515
-
项目类别:
-
资助金额:$35.86万
-
财政年份:2022
-
负责人:Anissa Abi-Dargham
-
依托单位:
Preliminary imaging studies of the kappa opioid receptors in schizophrenia and their relationship to dopamine function
-
批准号:10304170
-
项目类别:
-
资助金额:$19.94万
-
财政年份:2020
-
负责人:Anissa Abi-Dargham
-
依托单位:
Neurobiological correlates of auditory processing in health and disease: an RDoC study
-
批准号:9080754
-
项目类别:
-
资助金额:$73.25万
-
财政年份:2016
-
负责人:Anissa Abi-Dargham
-
依托单位:
Probing dopamine D2 receptor trafficking in schizophrenia
-
批准号:8712557
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2013
-
负责人:Anissa Abi-Dargham
-
依托单位:
Probing dopamine D2 receptor trafficking in schizophrenia
-
批准号:8584066
-
项目类别:
-
资助金额:$25.49万
-
财政年份:2013
-
负责人:Anissa Abi-Dargham
-
依托单位:
Dopamine Dysfunction in Schizophrenia
-
批准号:8102708
-
项目类别:
-
资助金额:$193.6万
-
财政年份:2010
-
负责人:Anissa Abi-Dargham
-
依托单位:
Dopamine Dysfunction in Schizophrenia
-
批准号:8448257
-
项目类别:
-
资助金额:$177.26万
-
财政年份:2010
-
负责人:Anissa Abi-Dargham
-
依托单位:
Dopamine Dysfunction in Schizophrenia
-
批准号:7940012
-
项目类别:
-
资助金额:$199.85万
-
财政年份:2010
-
负责人:Anissa Abi-Dargham
-
依托单位:
Dopamine Dysfunction in Schizophrenia
-
批准号:8249495
-
项目类别:
-
资助金额:$188.94万
-
财政年份:2010
-
负责人:Anissa Abi-Dargham
-
依托单位:
Dopamine Dysfunction in Schizophrenia
-
批准号:8650332
-
项目类别:
-
资助金额:$180.53万
-
财政年份:2010
-
负责人:Anissa Abi-Dargham
-
依托单位:
Cortical and Striatal Dopamine Dysfunction in Addiction and Schizophrenia
-
批准号:7738569
-
项目类别:
-
资助金额:$12.37万
-
财政年份:2009
-
负责人:Anissa Abi-Dargham
-
依托单位:
Cortical and Striatal Dopamine Dysfunction in Addiction and Schizophrenia
-
批准号:7924734
-
项目类别:
-
资助金额:$12.37万
-
财政年份:2009
-
负责人:Anissa Abi-Dargham
-
依托单位:
Cortical and Striatal Dopamine Dysfunction in Addiction and Schizophrenia
-
批准号:8131905
-
项目类别:
-
资助金额:$12.37万
-
财政年份:2009
-
负责人:Anissa Abi-Dargham
-
依托单位:
Cortical and Striatal Dopamine Dysfunction in Addiction and Schizophrenia
-
批准号:8534844
-
项目类别:
-
资助金额:$12.37万
-
财政年份:2009
-
负责人:Anissa Abi-Dargham
-
依托单位:
Cortical and Striatal Dopamine Dysfunction in Addiction and Schizophrenia
-
批准号:8318271
-
项目类别:
-
资助金额:$12.37万
-
财政年份:2009
-
负责人:Anissa Abi-Dargham
-
依托单位:
Imaging dopamine transmission in comorbid schizophrenia and cannabis dependence
-
批准号:7384577
-
项目类别:
-
资助金额:$18.65万
-
财政年份:2008
-
负责人:Anissa Abi-Dargham
-
依托单位:
Imaging dopamine transmission in comorbid schizophrenia and cannabis dependence
-
批准号:7568789
-
项目类别:
-
资助金额:$16.26万
-
财政年份:2008
-
负责人:Anissa Abi-Dargham
-
依托单位:
Imaging dopamine transmission in cannabis dependence
-
批准号:7759602
-
项目类别:
-
资助金额:$38.91万
-
财政年份:2007
-
负责人:Anissa Abi-Dargham
-
依托单位:
CORE--CLINICAL
-
批准号:7457815
-
项目类别:
-
资助金额:$8.86万
-
财政年份:2007
-
负责人:Anissa Abi-Dargham
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: